英文别名: |
2-(4-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropanoic acid;Ciprofibrate;Win35833;2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid;2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropionic Acid;2-[p-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid;2-[p-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid,Ciprofibrate;Lipanor;Ciprofibratum;Ciprofibrato;Modalim;Ciprofibratum [INN-Latin];Ciprofibrato [INN-Spanish];WIN 35833;C13H14Cl2O3;Propanoic acid, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methyl-;2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acid;2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methyl;SR-01000075734-4;Prestwick3_001076;CCRIS 173;BRD-A49358627-001-10-4;Ciprofibrate (USAN/INN);BRN 1984981;CHEBI:50867;SR-01000075734;Prestwick2_001076;Tox21_112121;SMR000857190;BCP0726000148;FT-0602946;NCGC00256361-01;CHEMBL557555;AKOS005557843;NCGC00258911-01;Tox21_112121_1;NCGC00015202-08;NCGC00015202-05;Q3496452;NSC-759617;CIPROFIBRATE [USAN];CIPROFIBRATE [EP MONOGRAPH];52214-84-3;Prestwick0_001076;BCPP000277;Prestwick1_001076;CIPROFIBRATE [MART.];NSC 759617;s2665;HY-B0664;Hiperlipen;C 0330;BRD-A49358627-001-03-9;NCGC00164447-01;CIPROFIBRATE [EP IMPURITY];EN300-18557337;Ciprofibrate- Bio-X;CAS-52214-84-3;NCGC00260853-01;Tox21_302840;C2667;2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methylpropanoic acid;DTXSID8020331;HMS3260B17;KS-1201;2-[4-[2,2-bis(chloranyl)cyclopropyl]phenoxy]-2-methyl-propanoic acid;NCGC00093652-02;AC-1018;O10468;NS00032454;EU-0100168;SDCCGSBI-0050156.P002;2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid;SPBio_002996;Ciprofibrate for system suitability;HMS1571G14;BDBM50371235;BCP03728;Pharmakon1600-01502008;MLS002154143;Ciprofibrate for system suitability, European Pharmacopoeia (EP) Reference Standard;D03521;BSPBio_001092;HMS3369B22;NCGC00015202-06;2-{[4-(2,2-dichlorocyclopropyl)phenyl]oxy}-2-methylpropanoic acid;J-520054;NCGC00015202-21;HMS2098G14;2-[p-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropionic acid;Tox21_201359;AB00514032;Ciprofibrate, European Pharmacopoeia (EP) Reference Standard;Ciprofibrate; 2-[4-[(1RS)-2,2-Dichlorocyclopropyl]phenoxy]-2-methylpropanoic acid;Tox21_500168;AB00514032_06;CIPROFIBRATE [WHO-DD];NCGC00093652-01;HMS3656P09;MFCD00467135;GTPL3438;NSC759617;NCGC00015202-03;SY052727;SW197242-4;CCG-204263;BPBio1_001202;SR-01000075734-7;Win-35833;HMS2235J14;NCGC00015202-04;CIPROFIBRATE [MI];2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methylpropanoic acid;A828985;SCHEMBL26870;MLS006011758;DTXCID20331;SR-01000075734-1;NCGC00015202-20;EINECS 257-744-6;Ciprol;HMS3715G14;BD164311;NCGC00015202-02;Ciprofibrate [USAN:INN:BAN];Lopac0_000168;LP00168;BCP9000533;Propanoic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl-;F8252JGO9S;DB09064;CIPROFIBRATE [INN];Ciprofibrate?;UNII-F8252JGO9S |